Publications in collaboration with researchers from London School of Hygiene & Tropical Medicine (24)

2023

  1. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study

    The Lancet Global Health, Vol. 11, Núm. 2, pp. e218-e228

  2. Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study

    Clinical and Experimental Allergy, Vol. 53, Núm. 3, pp. 337-352

2022

  1. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network

    Pediatric Allergy and Immunology, Vol. 33, Núm. 1

  2. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

  3. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

  4. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I

    Pediatric Allergy and Immunology, Vol. 33, Núm. 1

2021

  1. Improving lung health in low-income and middle-income countries: from challenges to solutions

    The Lancet, Vol. 397, Núm. 10277, pp. 928-940

  2. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

    The Lancet, Vol. 398, Núm. 10311, pp. 1569-1580

2020

  1. Comparison of individual-level and population-level risk factors for rhinoconjunctivitis, asthma, and eczema in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three

    World Allergy Organization Journal, Vol. 13, Núm. 6

  2. Global asthma network phase i surveillance: geographical coverage and response rates

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-17

  3. Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy

    Clinical and Translational Oncology, Vol. 22, Núm. 6, pp. 852-859

  4. Trends in worldwide asthma prevalence

    European Respiratory Journal, Vol. 56, Núm. 6

2019

  1. Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?

    Journal of Investigative Dermatology, Vol. 139, Núm. 5, pp. 1023-1036

  2. Are environmental risk factors for current wheeze in the international study of asthma and allergies in childhood (ISAAC) phase three due to reverse causation?

    Clinical and Experimental Allergy, Vol. 49, Núm. 4, pp. 430-441

  3. Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?

    The Lancet Respiratory Medicine

  4. Combined impact of healthy lifestyle factors on risk of asthma, rhinoconjunctivitis and eczema in school children: ISAAC phase III

    Thorax, Vol. 74, Núm. 6, pp. 531-538

2017

  1. Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 105-114

  2. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors

    European Respiratory Journal, Vol. 49, Núm. 1

2015

  1. Global prevention and control of NCDs: Limitations of the standard approach

    Journal of Public Health Policy, Vol. 36, Núm. 4, pp. 408-425

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270